Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Lawrence M. Pfeffer
Introduction
Lawrence M. Pfeffer is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly through his innovative methods in detecting sensitivity to alpha-interferon therapy. His work has implications for improving treatment strategies for patients undergoing this therapy.
Latest Patents
Pfeffer holds a patent for a method to detect sensitivity to alpha-interferon therapy. This invention provides a method of detecting sensitivity by contacting a sample with a monoclonal antibody under conditions that allow for the formation of an antibody-antigen complex. The detection of this complex enables the identification of sensitivity to alpha-interferon, which can be crucial for tailoring patient treatments. He has 1 patent to his name.
Career Highlights
Lawrence M. Pfeffer is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts his research and develops innovative solutions to complex medical challenges. His work at this prestigious institution underscores his commitment to advancing cancer treatment methodologies.
Collaborations
Pfeffer has collaborated with esteemed colleagues such as Anthony P. Albino and David M. Nanus. These collaborations enhance the research environment and contribute to the development of effective cancer therapies.
Conclusion
Lawrence M. Pfeffer's contributions to cancer research through his innovative patent demonstrate his dedication to improving patient outcomes. His work continues to influence the field and offers hope for advancements in cancer treatment.